URL Pharma - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

URL Pharma M&A Summary

URL Pharma has acquired 1 company of its own.

URL Pharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

URL Pharma Ownership

Who owns URL Pharma?

URL Pharma is owned by Caraco Pharmaceutical Laboratories. It was acquired on December 17, 2012.

URL Pharma Business Overview

Where is URL Pharma headquartered?

URL Pharma is headquartered in Philadelphia, Pennsylvania.

What sector is URL Pharma in?

URL Pharma is a life science company.

When was URL Pharma founded?

URL Pharma was founded in 1946.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

URL Pharma, Inc.

1100 Orthodox Street,
Philadelphia, Pennsylvania 19124
United States,
(215) 288-6500
www.urlpharma.com

URL Pharma, Inc. is a manufacturer of branded and generic medicines. Its core products include Qualaquin, Colcrys, Fibricor, and Bactrim.


M&A Summary

Buy vs Sell

Year ≤ '04 '05 '06 '07 '08 '09 T
Buy (0.2/yr) # - - - - - 1 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
PharmPro Services 2009-08-03 - Add-on Acquisition
Aurora, Illinois
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  Illinois 1 - - -
Total 1 - - -

 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.